These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 2285241)
1. Chromosomal modifications of a rat glioblastoma cell line during the acquisition and reversal of doxorubicin resistance. Montaudon D; Benchekroun MN; Londos-Gagliardi D; Robert J Anticancer Res; 1990; 10(6):1667-75. PubMed ID: 2285241 [TBL] [Abstract][Full Text] [Related]
2. Identification and fate of a marker chromosome in methotrexate-resistant V79,B7 cells by flow karyotyping and sorting, metaphase analysis and in situ hybridization. NĂ¼sse M; Viaggi S; Bonatti S Anal Cell Pathol; 1992 Sep; 4(5):345-58. PubMed ID: 1445793 [TBL] [Abstract][Full Text] [Related]
3. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line. Hill AB; Beck WT; Trent JM Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436 [TBL] [Abstract][Full Text] [Related]
4. Cytogenetic alterations associated with the acquisition of doxorubicin resistance: possible significance of chromosome 7 alterations. Slovak ML; Hoeltge GA; Trent JM Cancer Res; 1987 Dec; 47(24 Pt 1):6646-52. PubMed ID: 3677098 [TBL] [Abstract][Full Text] [Related]
5. Fluorescence anisotropy of cell membranes of doxorubicin-sensitive and -resistant rodent tumoral cells. Montaudon D; Vrignaud P; Londos-Gagliardi D; Robert J Cancer Res; 1986 Nov; 46(11):5602-5. PubMed ID: 3756908 [TBL] [Abstract][Full Text] [Related]
6. Relationships between DNA damage and growth inhibition induced by topoisomerase II-interfering drugs in doxorubicin-sensitive and -resistant rat glioblastoma cells. de Tinguy-Moreaud E; Pourquier P; Montaudon D; Robert J Anticancer Res; 1994; 14(1A):99-103. PubMed ID: 8166463 [TBL] [Abstract][Full Text] [Related]
7. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Fairchild CR; Ivy SP; Kao-Shan CS; Whang-Peng J; Rosen N; Israel MA; Melera PW; Cowan KH; Goldsmith ME Cancer Res; 1987 Oct; 47(19):5141-8. PubMed ID: 2441861 [TBL] [Abstract][Full Text] [Related]
8. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage. Bellamy WT; Dalton WS; Kailey JM; Gleason MC; McCloskey TM; Dorr RT; Alberts DS Cancer Res; 1988 Nov; 48(22):6365-70. PubMed ID: 3180056 [TBL] [Abstract][Full Text] [Related]
9. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Goldenberg GJ; Wang H; Blair GW Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020 [TBL] [Abstract][Full Text] [Related]
10. Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone. Dalton WS; Cress AE; Alberts DS; Trent JM Cancer Res; 1988 Apr; 48(7):1882-8. PubMed ID: 2894893 [TBL] [Abstract][Full Text] [Related]
11. Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration. Bellamy WT; Dorr RT; Dalton WS; Alberts DS Cancer Res; 1988 Nov; 48(22):6360-4. PubMed ID: 3180055 [TBL] [Abstract][Full Text] [Related]
12. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875 [TBL] [Abstract][Full Text] [Related]
13. Altered topoisomerase II alpha in a drug-resistant small cell lung cancer cell line selected in VP-16. Mirski SE; Evans CD; Almquist KC; Slovak ML; Cole SP Cancer Res; 1993 Oct; 53(20):4866-73. PubMed ID: 8104687 [TBL] [Abstract][Full Text] [Related]
14. [Cloning and characteristics of DNA sequences amplified in Djungarian hamster cells with multidrug resistance]. Chernova OB; Shifrin VI; Sokova OI; Kopnin BP; Gudkov AV Mol Gen Mikrobiol Virusol; 1987 Apr; (4):14-9. PubMed ID: 3600679 [TBL] [Abstract][Full Text] [Related]
15. Chromosomal organization of amplified genes in multidrug-resistant Chinese hamster cells. Biedler JL; Chang TD; Scotto KW; Melera PW; Spengler BA Cancer Res; 1988 Jun; 48(11):3179-87. PubMed ID: 3365701 [TBL] [Abstract][Full Text] [Related]
16. The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. Slovak ML; Ho JP; Cole SP; Deeley RG; Greenberger L; de Vries EG; Broxterman HJ; Scheffer GL; Scheper RJ Cancer Res; 1995 Oct; 55(19):4214-9. PubMed ID: 7671223 [TBL] [Abstract][Full Text] [Related]
17. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA. Harker WG; Sikic BI Cancer Res; 1985 Sep; 45(9):4091-6. PubMed ID: 4028002 [TBL] [Abstract][Full Text] [Related]
18. Model for the formation of double minutes from prematurely condensed chromosomes of replicating micronuclei in drug-treated Chinese hamster ovary cells undergoing DNA amplification. Sen S; Hittelman WN; Teeter LD; Kuo MT Cancer Res; 1989 Dec; 49(23):6731-7. PubMed ID: 2819718 [TBL] [Abstract][Full Text] [Related]
19. High-level, unstable adriamycin resistance in a Chinese hamster mutant cell line with double minute chromosomes. Howell N; Belli TA; Zaczkiewicz LT; Belli JA Cancer Res; 1984 Sep; 44(9):4023-9. PubMed ID: 6744317 [TBL] [Abstract][Full Text] [Related]
20. Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. Dalton WS; Durie BG; Alberts DS; Gerlach JH; Cress AE Cancer Res; 1986 Oct; 46(10):5125-30. PubMed ID: 2875788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]